Robert DeJoy
- Infectious Diseases top 5%
- Neurology top 10%
- Oncology
- Applied Microbiology and Biotechnology top 5%
- Epidemiology
- Co-authors
- Kevin Bryan LoGabriel Patarroyo‐AponteFahad GulRuchika BhargavGrace SalacupZurab AzmaiparashviliJeri AlbanoJerald Pelayo
- Topics
- COVID-19 Clinical Research Studies (9 papers)Long-Term Effects of COVID-19 (4 papers)Cardiac Arrest and Resuscitation (3 papers)
- Cited by
- Applied Microbiology and BiotechnologyInfectious DiseasesCritical Care and Intensive Care Medicine
- Partner nations
- United States
In The Last Decade
Robert DeJoy
13 papers receiving 388 citations
Peers
Comparison fields: 5 of 72
- Infectious Diseases 283
- Neurology 125
- Oncology 86
- Applied Microbiology and Biotechnology 65
- Epidemiology 62
Countries citing papers authored by Robert DeJoy
This map shows the geographic impact of Robert DeJoy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert DeJoy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert DeJoy more than expected).
Fields of papers citing papers by Robert DeJoy
This network shows the impact of papers produced by Robert DeJoy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert DeJoy. The network helps show where Robert DeJoy may publish in the future.
Co-authorship network of co-authors of Robert DeJoy
This figure shows the co-authorship network connecting the top 25 collaborators of Robert DeJoy. A scholar is included among the top collaborators of Robert DeJoy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert DeJoy. Robert DeJoy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 20 | |
| 4 | 2 | |
| 5 | 16 | |
| 6 | 102 | |
| 7 | 72 | |
| 8 | 36 | |
| 9 | 64 | |
| 10 | 29 | |
| 11 | 2 | |
| 12 | 24 | |
| 13 | 1 | |
| 14 | 24 |
About Robert DeJoy
Robert DeJoy is a scholar working on Internal Medicine, Applied Microbiology and Biotechnology and Infectious Diseases, having authored 14 papers that have together received 394 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (9 papers), Long-Term Effects of COVID-19 (4 papers) and Cardiac Arrest and Resuscitation (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (65 citations), Infectious Diseases (283 citations) and Critical Care and Intensive Care Medicine (56 citations). Robert DeJoy has collaborated with scholars based in United States. Frequent co-authors include Kevin Bryan Lo, Gabriel Patarroyo‐Aponte, Fahad Gul, Ruchika Bhargav, Grace Salacup, Zurab Azmaiparashvili, Jeri Albano, Jerald Pelayo, Janani Rangaswami and Eric Peterson. Their work appears in journals such as Journal of Medical Virology, The American Journal of the Medical Sciences and Thrombosis Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.